11/18/2014 - 2:28pm

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, on Tuesday announced that Health Canada has approved its application for PrTeva-Celecoxib, the generic equivalent of PrCelebrex.

11/18/2014 - 1:21pm

Camber Pharmaceuticals on Monday announced their selection as a 2014 “Supplier of the Year” at Anda’s annual Supplier Strategy Meeting in Doral, Fla.

11/17/2014 - 6:46pm

Drug Store News caught up with Upsher-Smith chief commercial officer Rusty Field to discuss topiramate extended-release capsules, its new authorized generic to Qudexy XR.

11/17/2014 - 6:45pm

DSN spoke with Neas in late October to mark the 30th anniversary of the landmark Drug Price Competition and Patent Term Restoration Act — better known as the Hatch-Waxman Act. 

11/17/2014 - 6:45pm

Thirty years ago, Democratic and Republican members of Congress hammered out a rare and prescient bipartisan compromise bill that transformed the pharmaceutical landscape forever and unleashed the modern generic drug industry. That law, known as the Hatch-Waxman Act, has proven to be one of the most far-reaching and impactful pieces of legislation ever to shape the American healthcare system.

11/17/2014 - 6:41pm

In this issue, we explore the profile of health-seeking drug store shoppers, their pharmacy purchase behavior and the best times to reach this valuable audience with promotional messages.

11/17/2014 - 6:41pm

A recent study by Field Agent examined what consumers are planning to do to keep themselves and their families healthy this fall.

11/17/2014 - 11:26am

Pharmaceutical sales through HDMA-member traditional primary distributors reached nearly $305 billion in 2013.

11/13/2014 - 1:59pm

A new analysis released by Avalere Health Thursday found that Medicare Part D prescription drug plans are poised to increase significantly the use of coinsurance in 2015.